Ironwood Pharmaceuticals (IRWD) gains 2.5% AH after announcing a collaboration with Australian...

|About: Ironwood Pharmaceuticals, Inc. (IRWD)|By:, SA News Editor

Ironwood Pharmaceuticals (IRWD) gains 2.5% AH after announcing a collaboration with Australian drug developer Bionomics to develop and commercialize an anti-anxiety compound developed by the latter. It's stated Bionomics "could receive up to $345 million" in payments and research funding from Ironwood, as well as royalties on product sales.